R1 RCM Inc
NASDAQ:RCM
Intrinsic Value
R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. [ Read More ]
The intrinsic value of one RCM stock under the Base Case scenario is 18.95 USD. Compared to the current market price of 12.02 USD, R1 RCM Inc is Undervalued by 37%.
Valuation Backtest
R1 RCM Inc
Run backtest to discover the historical profit from buying and selling RCM stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
R1 RCM Inc
Current Assets | 633.3m |
Cash & Short-Term Investments | 173.6m |
Receivables | 363.8m |
Other Current Assets | 95.9m |
Non-Current Assets | 4.3B |
PP&E | 236.2m |
Intangibles | 3.9B |
Other Non-Current Assets | 150.6m |
Current Liabilities | 346.2m |
Accounts Payable | 22.7m |
Accrued Liabilities | 211.5m |
Other Current Liabilities | 112m |
Non-Current Liabilities | 1.9B |
Long-Term Debt | 1.6B |
Other Non-Current Liabilities | 292.1m |
Earnings Waterfall
R1 RCM Inc
Revenue
|
2.3B
USD
|
Cost of Revenue
|
-1.8B
USD
|
Gross Profit
|
484.5m
USD
|
Operating Expenses
|
-223.6m
USD
|
Operating Income
|
260.9m
USD
|
Other Expenses
|
-257.6m
USD
|
Net Income
|
3.3m
USD
|
Free Cash Flow Analysis
R1 RCM Inc
What is Free Cash Flow?
RCM Profitability Score
Profitability Due Diligence
R1 RCM Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Score
R1 RCM Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
RCM Solvency Score
Solvency Due Diligence
R1 RCM Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Score
R1 RCM Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RCM Price Targets Summary
R1 RCM Inc
According to Wall Street analysts, the average 1-year price target for RCM is 17.27 USD with a low forecast of 14.14 USD and a high forecast of 21 USD.
Ownership
RCM Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
RCM Price
R1 RCM Inc
Average Annual Return | 16.74% |
Standard Deviation of Annual Returns | 59.29% |
Max Drawdown | -77% |
Market Capitalization | 5.1B USD |
Shares Outstanding | 420 280 000 |
Percentage of Shares Shorted | 7.66% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. The company is headquartered in Chicago, Illinois and currently employs 10,200 full-time employees. The company went IPO on 2010-05-20. The firm's services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also improving patient, physician, and staff satisfaction for its customers. Its primary service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups. The company also offers modular services, allowing customers to engage for only specific components of its end-to-end RCM service offering, such as physician advisory services (PAS), practice management (PM), revenue integrity solutions (RIS), patient experience (PX), coding management, and business office services. Its PAS offering assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes.
Contact
IPO
Employees
Officers
The intrinsic value of one RCM stock under the Base Case scenario is 18.95 USD.
Compared to the current market price of 12.02 USD, R1 RCM Inc is Undervalued by 37%.